GnRH antagonists in ovarian stimulation for ICSI with oocyte restriction: a matched, controlled study. (Q48792978)

15 February 2018

title

GnRH antagonists in ovarian stimulation for ICSI with oocyte restriction: a matched, controlled study. (English)

1 reference

15 February 2018

author name string

Greco E

1

1 reference

15 February 2018

Litwicka K

2

1 reference

15 February 2018

Ferrero S

3

1 reference

15 February 2018

Baroni E

4

1 reference

15 February 2018

Sapienza F

5

1 reference

15 February 2018

Rienzi L

6

1 reference

15 February 2018

Romano S

7

1 reference

15 February 2018

Minasi MG

8

1 reference

15 February 2018

Tesarik J

9

1 reference

15 February 2018

publication date

1 May 2007

1 reference

15 February 2018

Reproductive BioMedicine Online

published in

1 reference

15 February 2018

volume

14

1 reference

15 February 2018

issue

5

1 reference

15 February 2018

page(s)

572-578

1 reference

15 February 2018

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

The new Italian IVF legislation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Procreative tourism and reproductive freedom

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Manipulation of human ovarian function: physiological concepts and clinical consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Ovarian stimulation for in-vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Pituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

The 2004 Italian legislation regulating assisted reproduction technology: a multicentre survey on the results of IVF cycles.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Relationship between meiotic spindle location with regard to the polar body position and oocyte developmental potential after ICSI.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Italian Law 40/2004: a view from the 'Wild West'.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Prognostic value of day 3 estradiol on in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

GnRH antagonists in ovarian stimulation for IVF.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

The probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

Assisted reproduction with in-vitro-cultured testicular spermatozoa in cases of severe germ cell apoptosis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961048-6

7 January 2021

10.1016/S1472-6483(10)61048-6

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

17509196

1 reference

15 February 2018